Thermo Fisher Scientific TMO Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | 53.1%-0.5pp | 53.3%-0.3pp | 53.5%-0.2pp | 53.4%-0.6pp | 53.6%0.0pp | |
| Return on assets | 26%+0.2pp | 26.2%+0.7pp | 26.2%+1.1pp | 25.9%+0.8pp | 25.8%+0.9pp | |
| Liquidity | ||||||
| Current ratio | 6.8×+0.1× | 7.1×+0.4× | 6.9×+0.1× | 7×+0.2× | 6.8×+0.3× | |
| Quick ratio | 5.3×0.0× | 5.5×+0.3× | 5.3×-0.1× | 5.4×+0.1× | 5.3×+0.3× | |
| Cash ratio | 1.4×0.0× | 1.5×0.0× | 1.1×-0.7× | 1.3×-0.6× | 1.4×-0.2× | |
| Leverage | ||||||
| Debt-to-equity | 3.2×+0.1× | 3.1×-0.1× | 3×-0.4× | 3×-0.5× | 3.1×-0.4× | |
| Debt-to-assets | 1.5×0.0× | 1.5×0.0× | 1.5×-0.1× | 1.5×-0.1× | 1.5×-0.1× | |
| Per Share | ||||||
| Book value per share | $549.12+7.4% | $540.20+8.2% | $528.38+7.7% | $520.99+8.6% | $511.21+9.1% | |
| Valuation | ||||||
| Market capitalization | $736.1B-11.8% | $741.23B-14.7% | $722.51B-17.4% | $775.65B-7.0% | $834.25B+1.2% | |
| Enterprise value | $880.82B-8.8% | $878.9B-12.3% | $856.63B-15.2% | $907.04B-6.3% | $966.23B+0.6% | |
| Price / earnings | 110.2×-22.4× | 112.3×-28.2× | 111.3×-32.1× | 121.8×-16.2× | 132.6×-6.7× | |
| Price / book | 14.2×-2.9× | 14.5×-3.7× | 14.4×-4.1× | 15.7×-2.4× | 17.1×-1.1× | |
| Free cash flow yield | 14%-0.3pp | 13.9%-0.3pp | 14.6%+0.8pp | 14.6%+0.7pp | 14.3%+1.3pp | |
| Earnings yield | 14.7%+2.5pp | 14.5%+3.0pp | 14.6%+3.4pp | 13.6%+2.0pp | 12.2%+0.7pp | |
| Dividend yield | 1.4%+0.3pp | 1.3%+0.3pp | 1.4%+0.3pp | 1.3%+0.2pp | 1.1%+0.1pp | |
| PEG ratio | 19×-3.9× | 17.4×-1,112× | 17.2×— | 22.8×— | 22.8×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Thermo Fisher Scientific's profit margins?
- Thermo Fisher Scientific (TMO) runs a 58.3% gross margin and a 17.2% operating margin, with a 15.2% net margin.
- Where do Thermo Fisher Scientific's ratios come from?
- Every ratio is computed from Thermo Fisher Scientific's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
